Arrhythmogenic right ventricular cardiomyopathy: Antiarrhythmic drugs, catheter ablation, or ICD?

Herz

Volumn 30, Issue 2, 2005, Pages 91-101

  Wichter, Thomas ^a   Paul, Matthias ^b   Eckardt, Lars ^b   Gerdes, Petra ^b   Kirchhof, Paulus ^b   Böcker, Dirk ^b   Breithardt, Günter ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Univ Klin Münster ^*

Author keywords

Cardiomyopathy; Catheter ablation; Implantable defibrillator; Right ventricle; Right ventricular dysplasia; Sudden death; Ventricular tachycardia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; DIGITALIS; DIURETIC AGENT; FAT; SODIUM CHANNEL BLOCKING AGENT; SOTALOL; VASODILATOR AGENT; VERAPAMIL;

ATHLETE; AUTONOMIC DYSFUNCTION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR RISK; CARDIOVERSION; CATHETER ABLATION; DEFIBRILLATOR; DEVICE INFECTION; DISPERSION; DRUG EFFICACY; DRUG SAFETY; EXERCISE; FREQUENCY ANALYSIS; HEART ARREST; HEART INFARCTION; HEART MUSCLE CONDUCTION SYSTEM; HEART MUSCLE REFRACTORY PERIOD; HEART PALPITATION; HEART RIGHT VENTRICLE DYSPLASIA; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; INTRACARDIAC THROMBOSIS; MEDICAL ASSESSMENT; MUSCLE ATROPHY; PACEMAKER FAILURE; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; SIDE EFFECT; SPORT; SUDDEN DEATH; SYNCOPE; TRAINING;

ANTI-ARRHYTHMIA AGENTS; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CATHETER ABLATION; DEATH, SUDDEN, CARDIAC; ELECTRIC COUNTERSHOCK; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC;

EID: 17744375168     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-005-2677-6     Document Type: Review

References (44)

1. Fontaine G, Fontaliran F, Frank R. Arrhythmogenic right ventricular cardiomyopathies: clinical forms and main differential diagnoses. Circulation 1998;97:1532-5.
2. Corrado D, Basso C, Thiene G, et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 1997;30:1512-20.
3. Thiene G, Nava A, Corrado D, et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988;318:129-33.
4. Marcus FI, Fontaine GH, Guiraudon G, et al. Right ventricular dysplasia: a report of 24 cases. Circulation 1982;65:384-98.
5. McKoy G, Protonotarios N, Crosby A, et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 2000;355:2119-24.
6. Rampazzo A, Nava A, Malacrida S, et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 2002;71:1200-6.
7. Gerull B, Heuser A, Wichter T, et al. Mutations in the desmosomal arm repeat protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 2004;36:1162-4.
8. Beffagna G, Occhi G, Nava A, et al. Regulatory mutations in transforming growth factor-β3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res 2005;65:366-73.
9. Wichter T, Schulze-Bahr E, Eckardt L, et al. Molecular mechanisms of inherited ventricular arrhythmias. Herz 2002;27:712-39.
10. Wichter T, Paul M, Breithardt G. Arrhythmogene rechtsventrikuläre Kardiomyopathie: sportmedizinische Aspekte. Dtsch Z Sportmed 2005:56:in press.
11. Marcus F, Fontaine G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review. PACE 1995;18:1298-314.
12. McKenna WJ, Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J 1994;71:215-8.
13. Wichter T, Schäfers M, Borggrefe M, et al. Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy: quantitative assessment of presynaptic norepinephrine re-uptake and postsynaptic β-adrenoceptor density using positron emission tomography. Circulation 2000;101:1552-8.
14. Corrado D, Basso C, Thiene G. Pathological findings in victims of sport-related sudden cardiac death. Sports Exerc Injury 1996;2:78-86.
15. Pinamonti B, Singara G, Salvi A, et al. Left ventricular involvement in right ventricular dysplasia. Am Heart J 1992;123:711-24.
16. Shen WK, Edwards WD, Hammill SC, et al. Is right ventricular dysplasia a specific finding in the cause of sudden death in young subjects? Eur Heart J 1994;15:Suppl:363.
17. Blomström-Lundqvist C, Sabel KG, Olsson SB. A long-term follow up of 15 patients with arrhythmogenic right ventricular dysplasia. Br Heart J 1987;58:477-88.
18. Canu G, Atallah G, Claudel JP, et al. Prognostic et évolution à long terme de la dysplasie arythmogène du ventricule droit. Arch Mal Coeur 1993;86:41-8.
19. Leclercq JF, Coumel P, Denjoy I, et al. Long-term follow-up after sustained monomorphic ventricular tachycardia: causes, pump failure, and empiric antiarrhythmic therapy that modify survival. Am Heart J 1991;121:1685-92.
20. Marcus FI, Fontaine GH, Frank R, et al. Long-term follow-up in patients with arrhythmogenic right ventricular disease. Eur Heart J 1989;10:Suppl D:68-73.
21. Wichter T, Borggrefe M, Haverkamp W, et al. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease: results in patients with inducible and noninducible ventricular tachycardia. Circulation 1992;86:29-37.
22. Wichter T, Borggrefe M, Böcker D, et al. What therapies to prevent sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy? In: Aliot E, Clementy J, Prystowsky EN, eds. Fighting sudden cardiac death: a worldwide challenge. Armonk: Futura, 2000:275-98.
23. Tonet J, Frank R, Fontaine G, et al. Efficacité de l'association de faibles doses de bêta-bloquants à l'amiodarone dans le traitement des tachycardies ventriculaires réfractaires. Arch Mal Coeur 1989;82:1511-7.
24. Berder V, Vauthier M, Mabo P, et al. Characteristics and outcome in arrhythmogenic right ventricular dysplasia. Am J Cardiol 1995;75:411-5.
25. Wichter T, Hindricks G, Kottkamp H, et al. Catheter ablation of ventricular tachycardia. In: Nava A, Rossi L, Thiene G, eds. Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Amsterdam: Elsevier Science, 1997:376-91.
26. Fontaine G, Tonet J, Gallais Y, et al. Ventricular tachycardia catheter ablation in arrhythmogenic right ventricular dysplasia: a 16-year experience. Curr Cardiol Rep 2000;2:498-506.
27. Stark SI, Arthur A, Lesh MD. Radiofrequency catheter ablation of ventricular tachycardia in right ventricular cardiomyopathy: use of concealed entrainment to identify the slow conduction isthmus bounded by an aneurysm and the tricuspid annulus. J Cardiovasc Electrophysiol 1996;7:967-71.
28. Ellison KE, Friedman PL, Ganz LI, et al. Entrainment mapping and radiofrequency catheter ablation of ventricular tachycardia in right ventricular dysplasia. J Am Coll Cardiol 1998;32:724-8.
29. Boulos M, Lashevsky I, Reisner S, et al. Electroanatomic mapping of arrhythmogenic right ventricular dysplasia. J Am Coll Cardiol 2001;38:2020-7.
30. Reithmann C, Hahnefeld A, Remp T, et al. Electroanatomic mapping of endocardial right ventricular activation as a guide for catheter ablation in patients with arrhythmogenic right ventricular dysplasia. PACE. 2003;26:1308-16.
31. Marchlinski FE, Zado E, Dixit S, et al. Electroanatomic substrate and outcome of catheter ablative therapy in for ventricular tachycardia in setting of right ventricular cardiomyopathy. Circulation 2004;110:2293-8.
32. Zou J, Cao K, Yang B, et al. Dynamic substrate mapping and ablation of ventricular tachycardias in right ventricular dysplasia. J Interv Card Electrophysiol 2004;11:37-45.
33. Shoda M, Kasanuki H, Ohnishi S, et al. Recurrence of new ventricular tachycardia after successful catheter ablation in patients with arrhythmogenic right ventricular dysplasia. Circulation 1992;86:Suppl 1):1-580.
34. Breithardt G, Wichter T, Haverkamp W, et al. Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease. Am Heart J 1994;127:Suppl:1151-8.
35. Link MS, Wang PJ, Haugh CJ, et al. Arrhythmogenic right ventricular dysplasia:clinical results with implantable cardioverter-defibrillators. J Interv Card Electrophysiol 1997;1:41-8.
36. Tavernier R, Gevaert S, De Sutter J, et al. Long-term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias. Heart 2001;85:53-6.
37. Wichter T, Paul M, Wollmann C, et al. Implantable cardioverter- defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Circulation 2004;109:1503-8.
38. Corrado D, Leoni L, Link MS, et al. Implantable cardioverter- defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2003;108:3084-91.
39. Rougin A, Bomma CS, Nasir K, et al. Implantable cardioverter- defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2004;43:1843-52.
40. Hodgkinson KA, Parfrey PS, Bassett AS, et al. The impact of implantable cardioverter defibrillator therapy on survival in autosomal dominant arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2005;45:400-8.
41. Wichter T, Breithardt G. Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: a role for genotyping in decision-making? J Am Coll Cardiol 2005;45:409-11.
42. Hamid MS, Norman M, Quraishi A, et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 2002;40:1445-50.
43. Basso C, Wichter T, Danieli GA, et al. Arrhythmogenic right ventricular cardiomyopathy: clinical registry and database, evaluation of therapies, pathology registry, DNA banking. Eur Heart J 2004;25:531-4.
44. Marcus FI, Towbin JA, Zareba W, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a multidisciplinary study - design and protocol. Circulation 2003;107:2975-8.